Zhang Yuan, Quan Zhengxue, Zhao Zenghui, Luo Xiaoji, Tang Ke, Li Jie, Zhou Xu, Jiang Dianming
Department of Orthopedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
PLoS One. 2014 May 2;9(5):e96265. doi: 10.1371/journal.pone.0096265. eCollection 2014.
To retrospectively compare the efficacy of the titanium mesh cage (TMC) and the nano-hydroxyapatite/polyamide66 cage (n-HA/PA66 cage) for 1- or 2-level anterior cervical corpectomy and fusion (ACCF) to treat multilevel cervical spondylotic myelopathy (MCSM).
A total of 117 consecutive patients with MCSM who underwent 1- or 2-level ACCF using a TMC or an n-HA/PA66 cage were studied retrospectively at a mean follow-up of 45.28 ± 12.83 months. The patients were divided into four groups according to the level of corpectomy (1- or 2-level corpectomy) and cage type used (TMC or n-HA/PA66 cage). Clinical and radiological parameters were used to evaluate outcomes.
At the one-year follow-up, the fusion rate in the n-HA/PA66 group was higher, albeit non-significantly, than that in the TMC group for both 1- and 2-level ACCF, but the fusion rates of the procedures were almost equal at the final follow-up. The incidence of cage subsidence at the final follow-up was significantly higher in the TMC group than in the n-HA/PA66 group for the 1-level ACCF (24% vs. 4%, p = 0.01), and the difference was greater for the 2-level ACCF between the TMC group and the n-HA/PA66 group (38% vs. 5%, p = 0.01). Meanwhile, a much greater loss of fused height was observed in the TMC group compared with the n-HA/PA66 group for both the 1- and 2-level ACCF. All four groups demonstrated increases in C2-C7 Cobb angle and JOA scores and decreases in VAS at the final follow-up compared with preoperative values.
The lower incidence of cage subsidence, better maintenance of the height of the fused segment and similar excellent bony fusion indicate that the n-HA/PA66 cage may be a superior alternative to the TMC for cervical reconstruction after cervical corpectomy, in particular for 2-level ACCF.
回顾性比较钛网融合器(TMC)和纳米羟基磷灰石/聚酰胺66融合器(n-HA/PA66融合器)用于单节段或双节段颈椎前路椎体次全切除融合术(ACCF)治疗多节段脊髓型颈椎病(MCSM)的疗效。
对117例连续接受单节段或双节段ACCF手术,使用TMC或n-HA/PA66融合器的MCSM患者进行回顾性研究,平均随访时间为45.28±12.83个月。根据椎体次全切除的节段(单节段或双节段椎体次全切除)和所使用的融合器类型(TMC或n-HA/PA66融合器)将患者分为四组。采用临床和影像学参数评估治疗效果。
在1年随访时,n-HA/PA66组的融合率在单节段和双节段ACCF中均高于TMC组,尽管差异无统计学意义,但在最终随访时两组手术的融合率几乎相等。在最终随访时,单节段ACCF中TMC组融合器下沉的发生率显著高于n-HA/PA66组(24%对4%,p = 0.01),双节段ACCF中TMC组与n-HA/PA66组之间的差异更大(38%对5%,p = 0.01)。同时,在单节段和双节段ACCF中,TMC组融合节段高度丢失均显著多于n-HA/PA66组。与术前值相比,所有四组在最终随访时C2-C7 Cobb角和JOA评分均增加,VAS评分降低。
融合器下沉发生率较低、融合节段高度维持较好以及相似的良好骨融合效果表明,n-HA/PA66融合器可能是颈椎椎体次全切除术后颈椎重建中TMC的更好替代方案,尤其是在双节段ACCF中。